These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 32378544

  • 1. Discovery of 1,3-Disubstituted 2,5-Diketopiperazine Derivatives as Potent Class I HDACs Inhibitors.
    Gong G, Qi J, Lv Y, Dong S, Cao C, Li D, Zhao R, Li Z, Chen X.
    Chem Pharm Bull (Tokyo); 2020; 68(5):466-472. PubMed ID: 32378544
    [Abstract] [Full Text] [Related]

  • 2. Design, Synthesis and Biological Evaluation of Novel Benzoylimidazole Derivatives as Raf and Histone Deacetylases Dual Inhibitors.
    Chen X, Gong G, Chen X, Song R, Duan M, Qiao R, Jiao Y, Qi J, Chen Y, Zhu Y.
    Chem Pharm Bull (Tokyo); 2019; 67(10):1116-1122. PubMed ID: 31582631
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and biological evaluation of novel isoindolinone derivatives as potent histone deacetylase inhibitors.
    Chen X, Zhao S, Li H, Wang X, Geng A, Cui H, Lu T, Chen Y, Zhu Y.
    Eur J Med Chem; 2019 Apr 15; 168():110-122. PubMed ID: 30802729
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps.
    Fan W, Zhang L, Wang X, Jia H, Zhang L.
    J Enzyme Inhib Med Chem; 2021 Dec 15; 36(1):707-718. PubMed ID: 33663315
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Design, synthesis and anticancer activity of novel valproic acid conjugates with improved histone deacetylase (HDAC) inhibitory activity.
    Ibrahim TS, Sheha TA, Abo-Dya NE, AlAwadh MA, Alhakamy NA, Abdel-Samii ZK, Panda SS, Abuo-Rahma GEA, Mohamed MFA.
    Bioorg Chem; 2020 Jun 15; 99():103797. PubMed ID: 32247939
    [Abstract] [Full Text] [Related]

  • 15. Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors.
    Nepali K, Chang TY, Lai MJ, Hsu KC, Yen Y, Lin TE, Lee SB, Liou JP.
    Eur J Med Chem; 2020 Jun 15; 196():112291. PubMed ID: 32325365
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
    Cheng C, Yun F, He J, Ullah S, Yuan Q.
    Eur J Med Chem; 2019 Jul 01; 173():185-202. PubMed ID: 31003060
    [Abstract] [Full Text] [Related]

  • 17. Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents.
    Zheng H, Dai Q, Yuan Z, Fan T, Zhang C, Liu Z, Chu B, Sun Q, Chen Y, Jiang Y.
    Bioorg Med Chem; 2022 Jan 01; 53():116524. PubMed ID: 34847495
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities.
    Chao SW, Chen LC, Yu CC, Liu CY, Lin TE, Guh JH, Wang CY, Chen CY, Hsu KC, Huang WJ.
    Eur J Med Chem; 2018 Jan 01; 143():792-805. PubMed ID: 29223096
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents.
    Cheng J, Qin J, Guo S, Qiu H, Zhong Y.
    Bioorg Med Chem Lett; 2014 Oct 01; 24(19):4768-4772. PubMed ID: 25182565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.